Charles E. Weeks
Impact in
- Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
-
- Carcinogens and Genotoxicity Assessment 11
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Thomas J. Slaga (9 shared papers)Andres J. Klein–Szanto (4 shared papers)Susan M. Fischer (4 shared papers)Mahmoud M. Abdel‐Monem (4 shared papers)Frederick Nelson (1 shared paper)Mark A. Tomai (1 shared paper)Richard Lloyd Miller (1 shared paper)John J. Reiners (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (4 papers)Biochemical and Biophysical Research Communications (3 papers)Carcinogenesis (2 papers)The Journal of Clinical Pharmacology (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United States
In The Last Decade
Charles E. Weeks
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Cancer Research 390
- Immunology 280
- Dermatology 96
- Pharmacology 91
- Molecular Biology 443
Countries citing papers authored by Charles E. Weeks
This map shows the geographic impact of Charles E. Weeks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Weeks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Weeks more than expected).
Fields of papers citing papers by Charles E. Weeks
This network shows the impact of papers produced by Charles E. Weeks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Weeks. The network helps show where Charles E. Weeks may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Weeks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 155 | |
| 2 | Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. | 1992 | 151 |
| 3 | 1982 | 150 | |
| 4 | 1982 | 141 | |
| 5 | 1980 | 133 | |
| 6 | 2005 | 107 | |
| 7 | 1994 | 95 | |
| 8 | Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. | 1978 | 71 |
| 9 | 1974 | 66 | |
| 10 | 1979 | 58 | |
| 11 | 2000 | 51 | |
| 12 | 1979 | 49 | |
| 13 | Specificity and mechanism(s) of promoter inhibitors in multistage promotion. | 1982 | 37 |
| 14 | Effects of structure of N-acyl-N-2-fluorenylhydroxylamines on arylhydroxamic acid acyltransferase, sulfotransferase, and deacylase activities, and on mutations in Salmonella typhimurium TA 1538. | 1980 | 36 |
| 15 | 1979 | 34 | |
| 16 | 1975 | 30 | |
| 17 | 1988 | 28 | |
| 18 | 1979 | 25 | |
| 19 | 1982 | 23 | |
| 20 | 1998 | 23 |
About Charles E. Weeks
Charles E. Weeks is a scholar working on Cancer Research, Pharmacology, Immunology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 1.6k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (11 papers), Polyamine Metabolism and Applications (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), interferon and immune responses (4 papers), Hormonal and reproductive studies (2 papers), Adrenal Hormones and Disorders (2 papers), Retinoids in leukemia and cellular processes (2 papers) and Immunotherapy and Immune Responses (2 papers). The work is most often cited by research in Cancer Research (390 citations), Immunology (280 citations), Dermatology (96 citations), Pharmacology (91 citations) and Molecular Biology (443 citations). Charles E. Weeks has collaborated with scholars based in United States. Frequent co-authors include Thomas J. Slaga, Andres J. Klein–Szanto, Susan M. Fischer, Mahmoud M. Abdel‐Monem, Frederick Nelson, Mark A. Tomai, Richard Lloyd Miller, John J. Reiners, Charles M. King and James F. Hatcher. Their work appears in journals such as Journal of Medicinal Chemistry, Biochemical and Biophysical Research Communications, Carcinogenesis, The Journal of Clinical Pharmacology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.